Jeanne dos Santos
Nurse Practitioner · Hawthorne, NYNPI 1962506105
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,362, 4.9 times the $280 reported in 2021. Among nurse practitioner clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$664
- Tolmar, Inc.$406
- Insulet Corporation$382
- Sanofi-aventis U.S. LLC$363
- Ascendis Pharma Endocrinology Inc$341
- Novo Nordisk$328
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,449100%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $664 |
| Tolmar, Inc. | 23 | $406 |
| Insulet Corporation | 10 | $382 |
| Sanofi-aventis U.S. LLC | 13 | $363 |
| Ascendis Pharma Endocrinology Inc | 15 | $341 |
| Novo Nordisk | 14 | $328 |
| Xeris Pharmaceuticals, Inc. | 13 | $290 |
| Azurity Pharmaceuticals, Inc. | 10 | $191 |
| Biomarin Pharmaceutical Inc. | 2 | $138 |
| AstraZeneca | 5 | $132 |
| Amneal Pharmaceuticals LLC | 6 | $130 |
| Lilly USA, LLC | 5 | $126 |
| Neurocrine Biosciences, Inc. | 4 | $120 |
| Endo Pharmaceuticals Inc. | 6 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $105 |
| Endo USA, Inc. | 4 | $71 |
| Pfizer | 3 | $70 |
| Tandem Diabetes Care, Inc. | 2 | $69 |
| Kyowa Kirin, Inc. | 2 | $56 |
| Medtronic | 3 | $55 |
| Abbott | 2 | $48 |
| Soleno Therapeutics, Inc. | 1 | $35 |
| Dexcom, Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Sanofi | 1 | $27 |
| Rhythm Pharmaceuticals, Inc. | 1 | $26 |
| Alcresta Therapeutics, Inc. | 1 | $26 |
| Tolmar Pharmaceuticals, Inc. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Intuity Medical Inc | 1 | $17 |
| IBSA Pharma Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$150
How this compares
$4,453 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.
Other nurse practitioner in Hawthorne
- Uloma IjomahHawthorne$15K
- Patricia McGoldrickNew York$202K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
- Kerry AhernEast Syracuse$55K
- Valerie StanleyAlbany$55K
- Jodi LogerfoNew York$48K
- Grace WlasowiczRochester$41K
- Melissa LevinElmhurst$34K
- Carla JungquistCanandaigua$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.